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ABSTRACT 
Background: Emergency department (ED) visits towards the end-of-life by patients with cancer are 
increasing over time. This is despite evidence of an association with poor patient and caregiver 
outcomes and most patients preferring home-based care.  
Aim: To identify socio-demographic and clinical factors associated with end-of-life ED visits, and 
determine the relationship between patients’ prior ED use and risk of multiple (≥2) visits in the last 
month of life. 
Design: Population-based cohort study. 
Setting/Participants: All adults who died from cancer, in England, between 01/04/2011 and 
31/03/2012. Our primary outcome was the adjusted odds ratio for multiple ED visits in the last 
month of life, derived using multivariable logistic regression. 
Results: Among 124,030 cancer decedents (52.9% men; mean age 74.1 years), 30.7% visited the ED 
once in their last month of life and 5.1% visited multiple times. Patients were more likely to visit 
multiple times if they were men, younger, Asian or Black, of lower socio-economic status, had 
greater co-morbidity, and lung or head and neck cancer. Patients with ≥4 ED visits in the 11 months 
prior to their last month of life were also more likely to make multiple visits during their last 30 days; 
this followed a dose-response pattern (p for trend<0.001).  
Conclusion: Patients with greater co-morbidity, lung or head and neck cancer and a higher number 
of previous ED visits are more likely to visit the ED multiple times in the last month of life. Previously 
reported socio-demographic factors (men; younger age; Black; low socio-economic status) are also 
confirmed for the first time in a UK population.  
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KEY STATEMENTS 
What is already known about the topic 
 Emergency department (ED) visits towards the end-of-life by patients with cancer are increasing 
over time. This is despite: 
o An association with poor patient and caregiver outcomes; 
o The majority of patients preferring home-based care; and,  
o Most ED’s facing significant financial and capacity constraints. 
What this paper adds 
 This study identifies socio-demographic (male sex; younger age; Asian or Black ethnicity; lower 
socio-economic status) and clinical factors (greater co-morbidity; diagnosis of lung or head and 
neck cancer) associated with an increased odds of multiple (≥2) ED visits by patients with cancer 
in the last month of life.  
 Patients with a higher number of previous ED visits were also found to have a greater odds of 
multiple ED visits in the last month of life (adjusted odds ratio for ≥7 previous visits 1.81, 95% 
confidence interval 1.58-2.07, reference no visits); this followed a dose-response pattern (p for 
trend<0.001).  
Implications for practice, theory or policy 
 These findings can help healthcare professionals, managers and policy-makers to identify patients 
at increased risk of multiple ED visits towards the end-of-life, therefore allowing additional 
support services and/ or alternative care pathways to be provided.  
 Further research exploring the mechanism of action for the risk factors identified is required.   
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INTRODUCTION 
In 2012, an estimated 8.2 million people died from cancer worldwide.(1) Population growth and 
ageing mean that global cancer mortality is expected to rise further, increasing to an anticipated 
14.6 million deaths by 2035.(1) Issues pertaining to end-of-life care are consequently affecting a 
greater number of cancer patients each year and the importance of providing high-quality care, in 
accordance with patients’ needs and preferences, is increasingly recognised.(2) 
Towards the end-of-life people with cancer wish to be comfortable, spend time with their loved ones 
and have access to emotional and spiritual support as required (3-5). Most (64-84%) prefer to be 
cared for and die at home (6-9), and to avoid overly ‘aggressive’ care, which can be defined as care 
that focuses mostly or exclusively on disease-modifying treatments at the expense of good symptom 
management and/ or advance care planning (4, 10, 11). In addition to patients’ preferences, studies 
have found overly aggressive end-of-life cancer care to be associated with poor patient and 
caregiver outcomes, including prolonged pain, overall dissatisfaction with care and more than three 
times the odds of psychiatric illness in bereaved relatives (12-14). 
Less is known about the factors that may influence aggressive end-of-life cancer care.  Quantifying 
the aggressiveness of end-of-life cancer care is in itself challenging. Disease-related complications, 
adverse effects of treatment and/ or unrelated health conditions are all commonly experienced by 
patients with advanced cancer. To be optimally managed many of these situations require hospital-
based care. Deciding which hospital visits represent high-quality care versus those that signify overly 
aggressive care is complicated: good quality care for one patient may be considered overly 
aggressive by the next. To address this issue, Earle and colleagues developed a set of quality 
indicators which at a population-level could be used to identify healthcare systems delivering overly 
aggressive end-of-life cancer care (11, 15). In 2012, five of these performance measures were 
endorsed by the National Quality Forum in the United States of America (USA) (16). To date, these 
measures have not been used to examine the aggressiveness of end-of-life cancer care within the 
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National Health Service (NHS); a unique healthcare system that provides healthcare free for all at the 
point of delivery.  
This study seeks to understand and improve the quality of end-of-life cancer care by focusing on one 
of these validated performance measures – the proportion of cancer patients with multiple (≥2) 
emergency department (ED) visits in the last month of life. This measure was chosen becauseED 
visits often represent patients’ first contact with a healthcare professional when experiencing an 
acute or urgent symptom. This time is therefore critical when deciding factors such as place of care 
and intensity of treatment(17). Furthermore, ED visits in general and advanced cancer populations 
are rising (18-21) despite concerns of ED overcrowding and capacity constraints.  
In order to develop future services that can effectively reduce avoidable ED visits (whilst also 
supporting appropriate attendance for those in need), a comprehensive understanding of the factors 
influencing cancer patients’ ED visits is required. Knowledge of such factors could help healthcare 
professionals identify individuals at increased risk of multiple end-of-life ED visits, therefore allowing 
additional support services to be provided. In an earlier systematic review we identified 21 factors 
associated with ED visits by cancer patients in the last month of life (22). Our findings were, 
however, limited by the high proportion of studies conducted in the USA and Canada, and conflicting 
results relating to patients’ comorbidity, cancer diagnosis and rurality of usual place of residence. In 
order to address these gaps and allow development of more targeted approaches towards reducing 
end-of-life ED visits, we conducted a retrospective cohort study of 124,030 cancer decedents in 
England, UK. The aim of our study was to determine socio-demographic factors and clinical 
characteristics associated with end-of-life ED visits, and explore the relationship between patients’ 
prior ED use and the risk of multiple ED visits in the last month of life. 
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METHODS 
Our paper is reported following the RECORD statement – a checklist extended from STROBE and 
specific to reporting of observational studies using routinely collected health data.(23, 24) 
Approval for the study was received from NHS Digital (reference number: NIC-223311-Z0B8Q). As all 
data was pseudonymised, and therefore non-identifiable, no further approvals were required to 
complete the analysis. 
Design 
Population-based retrospective cohort study. 
Data Sources 
We used linked patient-level data from two routinely collected databases: the Office for National 
Statistics (ONS) Mortality Database and Hospital Episode Statistics (HES) Accident & Emergency 
Database.(25, 26) The ONS Mortality Database holds information on all UK deaths based on the 
information collected when a death is registered. It includes the ‘original underlying cause of death’ 
– that is the medical condition judged as the disease/ injury leading directly to death or 
circumstances of an accident or violence that resulted in fatal injury.(25) HES Accident & Emergency 
Database contains detailed patient-level data for all visits to NHS ED’s in England, UK. It includes 
both clinical data and information regarding the circumstances of a visit, for example date and 
time.(27) Linking ONS and HES data allows for analysis of patients’ hospital activity prior to death 
and is possible through matching person identifiable data in ONS with patient identifiers in HES. 
During the linkage process each record is assigned a match rank between one (best match) and eight 
(worse match), providing an indication of the level of confidence that the records have been 
matched correctly. Over 90% of linked ONS-HES records receive a match rank of one (requiring an 
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exact match of date of birth, sex, NHS number and postcode) or two (requiring an exact match of 
date of birth, sex and NHS number).(28)  
Study Cohort 
Our cohort, supplied by ONS, included all adults (≥18 years) who died from cancer (International 
Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) codes for 
underlying cause of death C00 to C97)(29) in England, during a one year period (01/04/2011 to 
31/03/2012) and had a valid record in HES. This cohort was linked to HES Accident & Emergency data 
for the same year and the preceding year, i.e. 01/04/2010 to 31/03/2012. This allowed us to 
quantify the number of ED visits each cancer decedent made in their last year of life. 
We excluded persons whose usual place of residence was outside England. We also excluded 
potentially inaccurate cases, including those with a data linkage match rank of three to eight, cases 
where patient activity was listed in the HES Accident & Emergency Database after the ONS recorded 
date of death, and cases where the date of death registration was more than one year after the 
documented date of death. 
Variables 
Outcome Variable  
Our primary outcome was the number of unplanned ED visits made by patients with cancer during 
their last month of life, dichotomised for analysis into those with none or one visit versus those with 
multiple (≥2) visits.(15) Planned ED visits – defined by HES as ‘subsequent organised visits to the 
same department and for the same incident as the first visit’ – were excluded (27).   
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Explanatory Variables 
Models of health seeking behaviour, including those specific to the ED, guided our selection of 
independent variables.(30, 31) We considered three groups of variables: socio-demographic factors; 
clinical characteristics; and, patients’ prior ED visits.  
Socio-demographic factors included sex (female reference), age at death (<65 (reference), 65-74, 75-
84 and 85+ years), ethnicity (White (reference), Asian, Black and other), region of England (North 
East, North West, Yorkshire & Humberside, East Midlands, West Midlands, East of England, London 
(reference), South East and South West), rurality of patients’ usual place of residence (urban - 
settlements with populations ≥10,000; rural - settlements with populations <10,000 (reference)), 
and socio-economic status which we derived from Index of Multiple Deprivation (IMD) quintiles (1 - 
most deprived; 5 - least deprived (reference)).(32) The IMD is an area based measure of deprivation 
that uses Lower Super Output Area (LSOA) geography to compare deprivation between 
neighbourhoods in England.(33)  
Clinical characteristics included cancer diagnosis, level of comorbidity and reason for ED visit, i.e. 
patients’ presenting symptom or medical condition. Cancer diagnosis was provided by ONS as an 
ICD-10 code representing the patients’ underlying cause of death and was categorised into 12 
groups: lung, breast, colorectal (reference), head and neck, haematological, upper gastrointestinal 
(including oesophagus and stomach), gynaecological, prostate, urinary tract (including kidney), 
hepatobiliary, pancreas and other. Similar to previous studies using HES data (34, 35) we calculated 
patients’ level of comorbidity using the Deyo modification of the Charlson comorbidity score with 
the points for malignant disease deducted.(36, 37) The score was calculated from data supplied by 
HES and encompassed a time period of up to two years prior to death. Patients were categorised 
into three groups: those with a comorbidity score of zero (reference), one or two plus. The reason 
for ED visit was provided by HES as either an ICD-10 code or a HES generated six character code that 
comprised information about the clinical condition (from 58 possible options), anatomical area and 
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side of body. These were grouped into 14 categories: respiratory; cardiovascular; diabetes and 
endocrinology; gastroenterology and hepatobiliary; genitourinary; haematology; ear nose and 
throat, facio-maxillary, ophthalmology and/or dermatology; neurology; musculoskeletal disorders 
and/ or injuries; psychiatry and/ or social problems; infection; pain; cancer/ tumour; and, other.  
Patients’ prior ED use was assessed as a single variable – the total number of ED visits made during 
the patient’s last year of life, excluding those in the last 30 days (reference group zero visits). 
Theoretical Framework 
This study was guided by Andersen and Newman’s ‘Behavioural Model of Health Services Use (38). 
In this model healthcare use is presented as a function of need, enabling resources and predisposing 
characteristics. As such we hypothesised that cancer patients’ end-of-life ED attendance would be 
influenced by their clinical characteristics, environmental factors and demographics.   
Statistical Analysis 
Counts and percentages were used to describe cancer patients with none, one, or multiple ED visits 
in the last month of life. The differences between patients with multiple ED visits and without (none 
or one ED visit combined) were explored using Chi square test. Factors associated with multiple ED 
visits were investigated using multivariable logistic regression, where we calculated adjusted odds 
ratios (AORs) and their corresponding 95% confidence intervals (CIs). Based on the findings of our 
recently published systematic review,(22) the multivariable logistic model included the following 
variables a priori: age; gender; ethnicity; socio-economic status; type of cancer; level of comorbidity. 
Additional variables were added if significant (p<0.05) at bivariate analysis.  
We calculated variance inflation factors (VIFs) to estimate how much of the variance of the 
regression coefficient was inflated due to correlation between explanatory variables in the model. 
We considered VIFs >2.5 to be indicative of multicollinearity.(39) The model’s goodness of fit was 
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assessed using the Hosmer-Lemeshow test.(39) Discrimination performance was calculated as area 
under the receive operating characteristic (ROC) curve. In this technique, the discrimination of the 
model is assessed by plotting the sensitivity of the test against 1 minus the specificity. The greater 
the area under the ROC curve (on a scale of 0.5-1), the better the model’s discrimination. 
Levels of missing data were examined and as ≤4% complete-case analysis performed.  
Stata/IC 13 (STATA, College Station, TX) was used for all statistical analysis.  
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RESULTS 
Between 01/04/2011 and 31/03/2012, there were 135,094 deaths from cancer in England of which 
129,042 (95.5%) had a valid record in HES. Patients with no record in any HES database were 
considered potentially inaccurate and therefore excluded.(40) A further 5,012 cases were excluded 
for other reasons (as described in figure 1), leaving 124,030 cases suitable for analysis (figure 1).  
Figure 1: Flow Diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ICD-10 – International Statistical Classification of Diseases and Related Health Problems 10th Revision, HES – Hospital Episode 
Statistics, ONS – Office for National Statistics, ED – emergency department 
All adult (≥18 years) deaths from cancer (ICD-10 codes 
C00 to C97) in England during a one year period 
(01/04/2011 to 31/03/2012)  
(n=135,094) 
Excluded (n=5,012) 
 ONS-HES match rank 3 to 8 
(n=1,444) 
 Patient activity listed in HES  
Accident & Emergency Database 
after ONS recorded date of death 
(n=1,196)  
 Date of death registration >1 year 
after patient’s documented date 
of death (n=252) 
 Patient’s usual place of residence 
outside of England (n=1,873) 
 Cases where the ED visit was 
recorded as planned or follow-up 
(n=247) 
 
Final cohort for analysis (n=124,030) 
 
Excluded (n=6,052) 
 No record in HES Database 
 
n=129,042 
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Among our cohort, mean age at death was 74.1 years (standard deviation 12.6); 52.9% were men. 
Almost all were White (96.1%) and the majority lived in an urban setting (78.2%). The most common 
cause of death was from lung cancer (21.5%) (table 1). 
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Table 1: Socio-demographic factors and clinical characteristics of study cohort (n=124,030) 
   Emergency department visits in last 30 days 
 Total sample None 1 visit ≥2 visits 
 N N (%) N (%) N (%) 
 124030 79656 64.2 38049 30.7 6325 5.1 
Age in years, mean (SD)  74.1 (12.6) 74.2 (12.6) 74.4 (12.3) 72.0 (13.1) 
Age in years         
<65 27528 17592 63.9 8189 29.8 1747 6.4 
65-74 31499 20059 63.7 9710 30.8 1730 5.5 
75-84 39764 25703 64.6 12233 30.8 1828 4.6 
85+ 25239 16302 64.6 7917 31.4 1020 4.0 
Gender         
Male 65649 40990 62.4 20928 31.9 3731 5.7 
Female 58381 38666 66.2 17121 29.3 2594 4.4 
Ethnicity         
White 114691 73865 64.4 35058 30.6 5768 5.0 
Asian  1793 916 51.1 686 38.3 191 10.7 
Black  1486 753 50.7 591 39.8 142 9.6 
Other 1383 782 56.5 500 36.2 101 7.3 
Cancer type         
Lung 26643 15525 58.3 9347 35.1 1771 6.7 
Breast 8852 5909 66.8 2528 28.6 415 4.7 
Colorectal 12135 8469 69.8 3234 26.7 432 3.6 
Head and Neck 2789 1782 63.9 814 29.2 193 6.9 
Haematology 10074 6186 61.4 3379 33.5 509 5.1 
Upper GI (inc Oesophagus & 
Stomach) 
12101 7959 65.8 3526 29.1 616 5.1 
Gynaecological 5939 4183 70.4 1525 25.7 231 3.9 
Prostate 8596 5678 66.1 2517 29.3 401 4.7 
Urinary tract (inc Kidney) 7384 4825 65.3 2247 30.4 312 4.2 
Hepatobiliary 3835 2462 64.2 1178 30.7 195 5.1 
Pancreas 6729 4424 65.8 1977 29.4 328 4.9 
Other 18953 12254 64.7 5777 30.5 922 4.9 
Comorbidity score$         
0 52616 36154 68.7 14322 27.2 2140 4.1 
1 37973 23675 62.4 12200 32.1 2098 5.5 
2+ 32053 18879 58.9 11107 34.7 2067 6.5 
Number of previous ED visits+         
0 44329 27333 61.7 15002 33.8 1994 4.5 
1 35877 24300 67.7 9928 27.7 1649 4.6 
2 20333 13371 65.8 5924 29.1 1038 5.1 
3 10692 6914 64.7 3148 29.4 630 5.9 
4 5667 3550 62.6 1753 30.9 364 6.4 
5 2984 1811 60.7 951 31.9 222 7.4 
6 1628 968 59.5 517 31.8 143 8.8 
7+ 2520 1409 55.9 826 32.8 285 11.3 
Socio-economic status (IMD 
quintile) 
        
1 – most deprived 23994 14246 59.4 8205 34.2 1543 6.4 
2 24534 15178 61.9 7952 32.4 1404 5.7 
3 26075 17127 65.7 7732 29.7 1216 4.7 
4 25731 17130 66.6 7450 29.0 1151 4.5 
5 – least deprived 23612 15914 67.4 6688 28.3 1010 4.3 
Region         
North East 7410 4741 64.0 2253 30.4 416 5.6 
North West 18003 11014 61.2 5951 33.1 1038 5.8 
Yorkshire & Humberside 13347 9267 69.4 3554 26.6 526 3.9 
East Midlands 11197 7852 70.1 2932 26.2 413 3.7 
West Midlands 13345 8610 64.5 4067 30.5 668 5.0 
East of England 13949 8623 61.8 4585 32.9 741 5.3 
London 12698 6534 51.5 5028 39.6 1136 9.0 
South East 20142 13169 65.4 6035 30.0 938 4.7 
South West 13938 9846 70.6 3643 26.1 449 3.2 
Rurality*         
Urban  96875 60836 62.8 30717 31.7 5322 5.5 
Rural 27071 18759 69.3 7310 27.0 1002 3.7 
SD – standard deviation, GI – gastrointestinal, ED – emergency department, IMD – index of multiple deprivation,  $Comorbidity score based on the Deyo 
modification of the Charlson comorbidity score with the points for malignant disease deducted, +Total number of ED visits in the last year of life excluding the 
last 30 days. *Rural - settlements with populations ≥10,000 and urban - settlements with populations <10,000. 
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In the last month of life, 30.7% (n=38,049) of patients visited the ED once, 4.5% (n=5,561) made two 
visits, 0.5% (n=654) made three, and 0.1% (n=110) made four or more. The number of visits ranged 
from 0 to 8 (median 0).  
Multivariable analysis found an association between multiple ED visits in the last month of life and 
the following socio-demographic factors: younger age, male sex (AOR 1.26, 95% CI 1.19–1.34), Asian 
(1.49, 1.27–1.74) or Black ethnicity (1.21, 1.01–1.46), lower socio-economic status, and living in an 
urban setting (1.18, 1.10–1.28) (table 2). Patients living in London were significantly more likely to 
visit the ED multiple times during their last month of life compared to those living in all other regions 
of England (table 2).  
Clinical characteristics associated with multiple ED visits were a greater level of comorbidity and a 
diagnosis of lung (1.74, 1.56–1.95) or head and neck cancer (1.67, 1.40–2.00) (table 2). For the 
variable “reason for ED visit” 1,271 patients left of were transferred from the ED before being seen 
and 1,909 patients either died in the ED or were dead on arrival. After excluding these patients we 
found respiratory conditions (19.6%), gastrointestinal and hepatobiliary conditions (13.3%), and 
musculoskeletal disorders/ injuries (including fractures) (11.8%) were most commonly reported. 
However, this information was not included in our multivariable model due to there also being high 
levels of missing and/ or invalid data. 
A dose-response pattern was found for the association between patients’ prior ED visits and their 
attendance in the last month of life. Compared to patients with no ED visits in the 11 months prior to 
the last month of life, the odds of multiple ED visits during their last 30 days increased with each 
additional visit, p for trend<0.001 (figure 2). 
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Table 2: Analysis of factors associated with multiple ED visits by patients with cancer in the last 30 
days of life (n=124,030) 
Variable OR 95% CI AOR 95% CI 
Age in years     
<65 1.00 - - - 
65-74 0.86 0.80 – 0.92 0.85 0.79 – 0.91 
75-84 0.71 0.66 – 0.76 0.70 0.65 – 0.75 
85+ 0.62 0.57 – 0.67 0.65 0.59 – 0.70 
Gender     
Female 1.00 - - - 
Male 1.30 1.23 – 1.36 1.26 1.19 – 1.34 
Ethnicity     
White 1.00 - - - 
Asian 2.25 1.93 – 2.62 1.49 1.27 – 1.74 
Black 2.00 1.67 – 2.38 1.21 1.01 – 1.46 
Other 1.49 1.21 – 1.82 1.10 0.89 – 1.35 
Cancer type     
Lung 1.93 1.73 – 2.15 1.74 1.56 – 1.95 
Breast 1.33 1.16 – 1.53 1.49 1.29 – 1.73 
Colorectal 1.00 - - - 
Head and Neck 2.01 1.69 – 2.40 1.67 1.40 – 2.00 
Haematology 1.44 1.26 – 1.64 1.32 1.15 – 1.51 
Upper GI (inc Oesophagus & Stomach) 1.45 1.28 – 1.65 1.37 1.21 – 1.56 
Gynaecological 1.10 0.93 – 1.29 1.19 1.01 – 1.41 
Prostate 1.33 1.15 – 1.52 1.21 1.05 – 1.40 
Urinary Tract (inc Kidney) 1.20 1.03 – 1.39 1.09 0.94 – 1.27 
Hepatobiliary 1.45 1.26 – 1.64 1.20 1.01 – 1.44 
Pancreas 1.39 1.15 – 1.52 1.34 1.16 – 1.56 
Other 1.39 1.23 – 1.56 1.33 1.18 – 1.50 
Comorbidity score$      
0 1.00 - - - 
1 1.38 1.30 – 1.47 1.31 1.23 – 1.39 
2+ 1.63 1.53 – 1.73 1.53 1.43 – 1.63 
Previous ED usage+     
0 1.00 - - - 
1 1.02 0.96 – 1.09 0.97 0.90 – 1.04 
2 1.14 1.06 – 1.23 0.99 0.92 – 1.07 
3 1.33 1.21 – 1.46 1.07 0.98 – 1.18 
4 1.46 1.30 – 1.64 1.13 1.00 – 1.27 
5 1.71 1.48 – 1.97 1.28 1.10 – 1.48 
6 2.04 1.71 – 2.44 1.48 1.24 – 1.78 
7+ 2.71 2.37 – 3.09 1.81 1.58 – 2.07 
Socio-economic status (IMD quintile)     
5 – least deprived 1.00 - - - 
4 1.05 0.96 – 1.14 1.03 0.94 – 1.12 
3 1.09 1.01 – 1.19 1.03 0.94 – 1.12 
2 1.36 1.25 – 1.48 1.12 1.03 – 1.23 
1 – most deprived 1.54 1.42 – 1.67 1.19 1.09 – 1.30 
Region     
London 1.00 - - - 
North East 0.61 0.54 – 0.68 0.66 0.58 – 0.75 
North West 0.62 0.57 – 0.68 0.68 0.62 – 0.75 
Yorkshire & Humberside 0.42 0.38 – 0.46 0.48 0.43 – 0.54 
East Midlands 0.39 0.35 – 0.44 0.47 0.41 – 0.53 
West Midlands 0.54 0.49 – 0.59 0.62 0.56 – 0.68 
East of England 0.57 0.52 – 0.63 0.72 0.65 – 0.80 
South East 0.50 0.45 – 0.54 0.62 0.56 – 0.68 
South West 0.34 0.30 – 0.38 0.43 0.38 – 0.49 
Rurality*     
Rural 1.00 - 1.00 - 
Urban 1.52 1.41 – 1.61 1.18 1.10 – 1.28 
OR – odds ratio, AOR – adjusted odds ratio, CI – confidence interval, GI – gastrointestinal, ED – emergency department, 
IMD – index of multiple deprivation,  $Comorbidity score based on the Deyo modification of the Charlson comorbidity 
score with the points for malignant disease deducted, +Total number of ED visits in the last year of life, excluding the 
last 30 days. *Rural - settlements with populations <10,000 and urban - settlements with populations ≥10,000. Figures 
in bold represent significant findings (p<0.01) 
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Figure 2: Relationship between cancer patients’ prior ED attendance and odds of multiple ED visits 
in the last 30 days of life 
 
 
  
Our multivariable model had a good overall fit (Hosmer-Lemeshow test chi2=8.78, p=0.36). 
Discrimination performance, calculated as area under the ROC curve, was 0.64. All variance inflation 
factors were ≤2.5 (mean 1.6).   
DISCUSSION 
In this population-based cohort study, we investigated socio-demographic factors and clinical 
characteristics associated with end-of-life ED visits, and explored the relationship between patients’ 
prior ED use and the risk of multiple ED visits in the last month of life. We found a dose-response 
relationship between patients’ prior ED use and their end-of-life ED visits, as well as an increased risk 
of multiple ED visits during the last month of life for patients with greater comorbidity and a 
diagnosis of lung or head and neck cancer. Previously reported socio-demographic factors (men; 
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younger age; Black ethnicity; low socio-economic status) were also confirmed for the first time in a 
UK population. Consistent with our study’s theoretical framework, we found cancer patients’ end-of-
life ED visits were influenced by clinical, environmental and demographic factors. A theoretical 
model illustrating the relationship and potential interaction between factors has been constructed 
from the findings (figure 3). 
Figure 3: Theoretical model illustrating the relationship between factors and ED visits by patients 
with cancer in the last 30 days of life 
 
 
 
 
 
 
 
 
 
 
 
 
 
Our finding of a dose-response relationship between patients’ prior ED use and their ED visits in the 
last month of life has not been previously reported in this population group. In prior work we have 
shown that patients receiving palliative care are less likely to visit the ED multiple times in the last 
month of life.(22) Furthermore, this reduction in odds appears to be greater when palliative care 
Previous ED Attendance 
 
Clinical Characteristics 
 
 
Socio-demographic Factors 
 
Level of Comorbidity 
Higher 
Cancer Type 
Lung 
Head and Neck 
Individual Demographics 
Younger age 
Male sex 
Asian or Black ethnicity 
 
Social and Environmental 
Lower socio-economic 
status 
Urban place of residence 
London residence 
 
4+ ED visits in last year of 
life, excluding last 30 days 
 
Increased odds of multiple ED 
visits in last 30 days of life 
Factors are listed under socio-demographic, clinical and previous ED attendance categories. Solid red lines 
indicate evidence from the present study of an association between factors and cancer patients’ ED 
attendance. Hatched red arrows indicate an association between groups of factors based on existing evidence 
and/ or theory, for example the relationship between patient age and cancer type. 
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services are provided earlier in a patients’ course of illness.(41-43) Yet despite these findings many 
referrals to palliative care still occur late and prompts that encourage earlier engagement are 
desirable.(44) Multiple presentations to the ED could be used as a trigger for additional support 
services and may be a more effective method of identifying individuals at increased risk of overly 
aggressive end-of-life care than screening of multiple socio-demographic and/ or clinical factors.(44) 
Our finding that patients with greater comorbidity are more likely to attend the ED multiple times is 
important. With the anticipated effects of population growth and ageing, the future average cancer 
patient will be older and likely to have ≥1 comorbidities.(45) With fewer hospital generalists and an 
overall trend towards increasing physician specialisation, collaboration between healthcare 
professionals is increasingly required when managing patients with multiple conditions.(46, 47) In 
order to deliver high-quality care to older more complex cancer patients, healthcare providers need 
to address the many well documented challenges associated with care coordination. Such challenges 
include: developing computer systems for effective communication and information sharing 
between services; providing timely and adequate information to patients and their caregivers; and, 
ensuring sufficient staffing and time.(48, 49) 
We also found an association between multiple ED visits and a diagnosis of lung or head and neck 
cancer. The relationship between cancer type and use of acute healthcare services is often 
attributed to the pattern of disease spread and/ or typical profile of symptoms seen with certain 
malignancies.(50, 51) For example, patients with head and neck cancer are at risk of complications 
that can compromise their airway. Our finding that patients with lung cancer have an increased odds 
of multiple ED visits is consistent with previously published research (18, 21, 52, 53) and alludes to 
breathlessness being a particularly difficult symptom to manage. Traditional approaches towards 
managing breathlessness often focus on symptom relief, which although ideal, is more often than 
not unrealistic, especially for patients with incurable disease. In a recently published randomised 
controlled trial Higginson and colleagues evaluated a breathlessness support service against usual 
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care for 105 adults with refractory breathlessness and advanced disease (including cancer).(54) The 
primary aim of the intervention was to help patients cope with or “master” their breathlessness 
rather than improve overall breathlessness severity scores. This novel approach to symptom 
management may be one way of reducing end-of-life acute hospital service use secondary to 
breathlessness, although further evaluation is required.  
We found that men, younger patients, Asian and Black ethnic minority groups, and persons of lower 
socio-economic status were more likely to visit the ED multiple times in the last month of life. These 
findings, reported for the first time in a UK population, support previously published studies from 
the United States and Canada and highlight the global extent of socio-demographic inequalities at 
the end-of-life.(18, 55, 56) Previous studies have explored whether this variation could be due to 
differences in patients’ understanding of their disease and prognosis or different preferences for 
end-of-life care across patient groups. (57-59) Whilst these studies have identified some important 
differences, the findings are unlikely to explain all the variation found. Further research aimed at 
understanding why such inequalities exist is urgently required. 
Our study found a significant area effect for London residents, even after controlling for rurality, 
suggesting that healthcare service factors, not just clinical need, are important in determining 
patients’ ED use at the end-of-life. A number of recently published studies have reported evidence of 
an association between increased use of community services and a reduced odds of end-of-life ED 
visits, hospital admissions and death in hospital.(60-62) Despite these findings, recent austerity 
measures have led to reductions in many community healthcare services across England. The 
structure of healthcare services is especially important to consider, as unlike many other factors 
such patient demographics, it represents a modifiable component of care. To help inform future 
healthcare planning and policy further research investigating the relationship between end-of-life ED 
visits and patients’ use of community services is required. 
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Strengths and Limitations 
One of the main strengths of our study is the use of patient-level population data to investigate end-
of-life ED visits by patients with cancer. ED visits do however represent only one indicator of end-of-
life care quality and as such our findings should be considered alongside other quality measures such 
as patients’ receipt of chemotherapy, use of hospice services and days spent in hospital or intensive 
care towards the end-of-life.(15) 
Analysis of routinely collected data can be limited by the type of variables collected and the quality 
of data coding. ONS mortality data go through stringent quality assessments prior to becoming 
available which along with the use of automated coding software help maintain consistency and 
overall data quality.(63) Recording of the underlying cause of death is however based on information 
obtained from a patient’s death certificate. Previous studies investigating death certificate 
completion have reported high levels of inaccuracy.(64) More recent evidence suggests this has 
improved and that deaths from cancer are more accurately reported than deaths from other 
conditions.(65, 66) We were not able to explore cause of death from the HES database. It is likely 
that our cohort included some patients whose cause of death was inaccurate, however the errors 
are not believed to have influenced our overall findings. 
The HES Accident & Emergency dataset contained few clinical variables and many were unsuitable 
for analysis due to high levels of missing or invalid data (including the variable ‘reason for ED visit’). 
There was also a lack of variables relating to patients’ use of community services such as palliative 
care. With analysis of routinely collected data becoming increasingly common in healthcare 
research, addressing the validity and reliability of clinically coded variables is an important next step 
towards maximising the value of such resources. 
Lastly, population trends can only ever be a guide for the care that any one individual will require at 
the end-of-life. In many situations the ED is the most appropriate setting for urgent care needs to be 
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managed and the importance of providing individualised patient-centered care should not be 
overlooked.   
CONCLUSIONS 
Patients’ with a greater number of prior ED visits, more comorbidities and diagnosis of lung or head 
and neck cancer are more likely to visit the ED multiple times in the last month of life. Previously 
reported socio-demographic factors (men; younger age; Black ethnicity; low socio-economic status) 
are also confirmed for the first time in a UK population. Flagging cancer patients who experience 
recurrent ED visits could support earlier identification of individuals at high-risk of overly aggressive 
end-of-life care. This may be a more effective and efficient approach than screening of multiple 
socio-demographic and/ or clinical factors. 
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